Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Times Interest Earned (2016 - 2017)

Historic Times Interest Earned for Pharma (IGC) over the last 9 years, with Q4 2017 value amounting to -$7.81.

  • Pharma's Times Interest Earned rose 595.74% to -$7.81 in Q4 2017 from the same period last year, while for Sep 2018 it was -$42.18, marking a year-over-year decrease of 41854.12%. This contributed to the annual value of -$9.19 for FY2017, which is 3231.54% up from last year.
  • Latest data reveals that Pharma reported Times Interest Earned of -$7.81 as of Q4 2017, which was up 595.74% from -$6.44 recorded in Q3 2017.
  • Pharma's 5-year Times Interest Earned high stood at -$2.33 for Q2 2013, and its period low was -$52.04 during Q1 2016.
  • Its 5-year average for Times Interest Earned is -$11.71, with a median of -$7.94 in 2014.
  • Its Times Interest Earned has fluctuated over the past 5 years, first soared by 8735.48% in 2013, then tumbled by 70848.7% in 2014.
  • Over the past 5 years, Pharma's Times Interest Earned (Quarter) stood at -$5.6 in 2013, then plummeted by 43.86% to -$8.06 in 2014, then increased by 8.73% to -$7.35 in 2015, then dropped by 13.01% to -$8.31 in 2016, then rose by 5.96% to -$7.81 in 2017.
  • Its Times Interest Earned stands at -$7.81 for Q4 2017, versus -$6.44 for Q3 2017 and -$8.9 for Q2 2017.